{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:35:39Z","timestamp":1793673339148,"version":"4.5.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Emerg Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Necrotizing soft tissue infections (NSTI) require immediate radical debridement, broad-spectrum antibiotics and intensive care. Hyperbaric oxygen therapy (HBOT) may be performed adjunctively, but unequivocal evidence for its benefits is still lacking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective single-center study including 192 patients with necrotizing fasciitis or Fournier's gangrene to assess in-hospital mortality and outcome dependent on patient, disease and treatment characteristics with or without HBOT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The in-hospital mortality rate was 27.6%. Factors associated with increased mortality according to multivariate analysis were higher age, affection of multiple or problem localizations (odds ratio (OR)\u2009=\u20092.88,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.003), ineligibility for HBOT despite clinical indication (OR\u2009=\u20098.59,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.005), pathogens in blood cultures (OR\u2009=\u20093.36,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002), complications (OR\u2009=\u200910.35,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and sepsis\/organ dysfunction (OR\u2009=\u200919.58,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Factors associated with better survival included vacuum-assisted wound closure (OR\u2009=\u20090.17,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), larger number of debridements (OR\u2009=\u20090.83,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and defect closure with mesh graft (OR\u2009=\u20090.06,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) or flap (OR\u2009=\u20090.09,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.024). When participants were stratified into subgroups without requirement of HBOT (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200998), treated with HBOT (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200983) and ineligible for HBOT due to contraindications (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200911), the first two groups had similar survival rates (75.5% vs. 73.5%) and comparable outcome, although patients with HBOT suffered from more severe NSTI, reflected by more frequent affection of multiple localizations (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), sepsis at admission (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and intensive care treatment (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), more debridements (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and a larger number of antibiotics (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001). In the subgroup ineligible for HBOT, survival was significantly worse (36.4%,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.022).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results point to a benefit from HBOT for treatment of NSTI in critically ill patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13017-022-00448-6","type":"journal-article","created":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T14:02:48Z","timestamp":1659708168000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Outcome of necrotizing fasciitis and Fournier's gangrene with and without hyperbaric oxygen therapy: a retrospective analysis over 10\u00a0years"],"prefix":"10.1186","volume":"17","author":[{"given":"Assen","family":"Mladenov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Diehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke K.","family":"Peitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,5]]},"reference":[{"issue":"6","key":"448_CR1","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2106\/JBJS.19.00591","volume":"102","author":"AA Hysong","year":"2020","unstructured":"Hysong AA, Posey SL, Blum DM, et al. Necrotizing fasciitis: pillaging the acute phase response. J Bone Joint Surg Am. 2020;102(6):526\u201337.","journal-title":"J Bone Joint Surg Am"},{"key":"448_CR2","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.biopha.2018.10.142","volume":"109","author":"MY Memar","year":"2019","unstructured":"Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother. 2019;109:440\u20137.","journal-title":"Biomed Pharmacother"},{"key":"448_CR3","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.bioflm.2019.100008","volume":"1","author":"P\u00d8 Jensen","year":"2019","unstructured":"Jensen P\u00d8, M\u00f8ller SA, Lerche CJ, et al. Improving antibiotic treatment of bacterial biofilm by hyperbaric oxygen therapy: not just hot air. Biofilm. 2019;1:100008.","journal-title":"Biofilm"},{"issue":"7","key":"448_CR4","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/23744235.2019.1597983","volume":"51","author":"J Faun\u00f8 Thrane","year":"2019","unstructured":"Faun\u00f8 Thrane J, Ovesen T. Scarce evidence of efficacy of hyperbaric oxygen therapy in necrotizing soft tissue infection: a systematic review. Infect Dis (Lond). 2019;51(7):485\u201392.","journal-title":"Infect Dis (Lond)"},{"issue":"3","key":"448_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/sur.2016.200","volume":"18","author":"CS Cocanour","year":"2017","unstructured":"Cocanour CS, Chang P, Huston JM, et al. Management and novel adjuncts of necrotizing soft tissue infections. Surg Infect (Larchmt). 2017;18(3):250\u201372.","journal-title":"Surg Infect (Larchmt)"},{"key":"448_CR6","first-page":"239","volume-title":"Hyperbaric oxygen therapy Indications","author":"A Caesar","year":"2019","unstructured":"Caesar A, Jacoby I. Necrotizing soft tissue infections. In: Moon RE, editor. Hyperbaric oxygen therapy Indications. 14th ed. Florida: Best Publishing Company; 2019. p. 239\u201362.","edition":"14"},{"issue":"1","key":"448_CR7","first-page":"24","volume":"47","author":"D Mathieu","year":"2017","unstructured":"Mathieu D, Marroni A, Kot J. Tenth European Consensus Conference on Hyperbaric Medicine: recommendations for accepted and non-accepted clinical indications and practice of hyperbaric oxygen treatment. Diving Hyperb Med. 2017;47(1):24\u201332.","journal-title":"Diving Hyperb Med."},{"issue":"11","key":"448_CR8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s00104-012-2283-0","volume":"83","author":"M Schmale","year":"2012","unstructured":"Schmale M, Fichtner A, Pohl C, John E, Bucher M. Hyperbare oxygenation bei nekrotisierenden Weichteilinfektionen: pro [Hyperbaric oxygenation for necrotizing soft tissue infections: pro]. Chirurg. 2012;83(11):973\u20139.","journal-title":"Chirurg"},{"issue":"8","key":"448_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"7","key":"448_CR10","doi-asserted-by":"publisher","first-page":"e0132775","DOI":"10.1371\/journal.pone.0132775","volume":"10","author":"T Borschitz","year":"2015","unstructured":"Borschitz T, Schlicht S, Siegel E, Hanke E, von Stebut E. Improvement of a clinical score for necrotizing fasciitis: \u201cpain out of proportion\u201d and high CRP levels aid the diagnosis. PLoS ONE. 2015;10(7):e0132775.","journal-title":"PLoS ONE"},{"issue":"1","key":"448_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.28920\/dhm51.1.34-43","volume":"51","author":"M Hedetoft","year":"2021","unstructured":"Hedetoft M, Bennett MH, Hyledegaard O. Adjunctive hyperbaric oxygen treatment for necrotising soft-tissue infections: a systematic review and meta-analysis. Diving Hyperb Med. 2021;51(1):34\u201343.","journal-title":"Diving Hyperb Med"},{"issue":"9","key":"448_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s00134-019-05730-x","volume":"45","author":"MB Madsen","year":"2019","unstructured":"Madsen MB, Skrede S, Perner A, et al. Patient\u2019s characteristics and outcomes in necrotising soft-tissue infections: results from a Scandinavian, multicentre, prospective cohort study. Intensive Care Med. 2019;45(9):1241\u201351.","journal-title":"Intensive Care Med"},{"issue":"6","key":"448_CR13","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/bjd.15615","volume":"177","author":"E Audureau","year":"2017","unstructured":"Audureau E, Hua C, de Prost N, et al. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007\u201312. Br J Dermatol. 2017;177(6):1575\u201382.","journal-title":"Br J Dermatol"},{"issue":"10","key":"448_CR14","doi-asserted-by":"publisher","first-page":"e041302","DOI":"10.1136\/bmjopen-2020-041302","volume":"10","author":"M Hedetoft","year":"2020","unstructured":"Hedetoft M, Madsen MB, Madsen LB, Hyldegaard O. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005\u20132018: a Danish nationwide register-based cohort study. BMJ Open. 2020;10(10):e041302.","journal-title":"BMJ Open"},{"key":"448_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13017-019-0286-6","volume":"15","author":"F Nawijn","year":"2020","unstructured":"Nawijn F, Smeeing DPJ, Houwert RM, Leenen LPH, Hietbrink F. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg. 2020;15:4.","journal-title":"World J Emerg Surg"},{"issue":"10219","key":"448_CR16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"9","key":"448_CR17","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1097\/00007611-200309000-00007","volume":"96","author":"DP Redman","year":"2003","unstructured":"Redman DP, Friedman B, Law E, Still JM. Experience with necrotizing fasciitis at a burn care center. South Med J. 2003;96(9):868\u201370.","journal-title":"South Med J"},{"issue":"5","key":"448_CR18","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00134-008-1373-4","volume":"35","author":"A Boyer","year":"2009","unstructured":"Boyer A, Vargas F, Coste F, et al. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med. 2009;35(5):847\u201353.","journal-title":"Intensive Care Med"},{"issue":"1","key":"448_CR19","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1097\/TA.0000000000001857","volume":"85","author":"RB Gelbard","year":"2018","unstructured":"Gelbard RB, Ferrada P, Yeh DD, et al. Optimal timing of initial debridement for necrotizing soft tissue infection: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2018;85(1):208\u201314.","journal-title":"J Trauma Acute Care Surg"},{"issue":"6","key":"448_CR20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/ans.12412","volume":"84","author":"D Proud","year":"2014","unstructured":"Proud D, Bruscino Raiola F, Holden D, Paul E, Capstick R, Khoo A. Are we getting necrotizing soft tissue infections right? A 10-year review. ANZ J Surg. 2014;84(6):468\u201372.","journal-title":"ANZ J Surg"},{"issue":"6","key":"448_CR21","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/0310057X1504300604","volume":"43","author":"B Devaney","year":"2015","unstructured":"Devaney B, Frawley G, Frawley L, Pilcher DV. Necrotising soft tissue infections: the effect of hyperbaric oxygen on mortality. Anaesth Intensive Care. 2015;43(6):685\u201392.","journal-title":"Anaesth Intensive Care"},{"issue":"7","key":"448_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00134-012-2558-4","volume":"38","author":"CR Soh","year":"2012","unstructured":"Soh CR, Pietrobon R, Freiberger JJ, et al. Hyperbaric oxygen therapy in necrotising soft tissue infections: a study of patients in the United States Nationwide Inpatient Sample. Intensive Care Med. 2012;38(7):1143\u201351.","journal-title":"Intensive Care Med"},{"key":"448_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-3-319-91287-5_42","volume":"1072","author":"T Steiner","year":"2018","unstructured":"Steiner T, Seiffart A, Schumann J, Bucher M. Hyperbaric oxygen therapy in necrotizing soft tissue infections: a retrospective study. Adv Exp Med Biol. 2018;1072:263\u20137.","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"448_CR24","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1001\/archsurg.139.12.1339","volume":"139","author":"D Wilkinson","year":"2004","unstructured":"Wilkinson D, Doolette D. Hyperbaric oxygen treatment and survival from necrotizing soft tissue infection. Arch Surg. 2004;139(12):1339\u201345.","journal-title":"Arch Surg"},{"issue":"2","key":"448_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.23736\/S0393-2249.20.03696-6","volume":"72","author":"M Creta","year":"2020","unstructured":"Creta M, Longo N, Arcaniolo D, et al. Hyperbaric oxygen therapy reduces mortality in patients with Fournier\u2019s Gangrene. Results from a multi-institutional observational study. Minerva Urol Nefrol. 2020;72(2):223\u20138.","journal-title":"Minerva Urol Nefrol."},{"issue":"3","key":"448_CR26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1089\/sur.2012.135","volume":"15","author":"JJ Shaw","year":"2014","unstructured":"Shaw JJ, Psoinos C, Emhoff TA, Shah SA, Santry HP. Not just full of hot air: hyperbaric oxygen therapy increases survival in cases of necrotizing soft tissue infections. Surg Infect (Larchmt). 2014;15(3):328\u201335.","journal-title":"Surg Infect (Larchmt)"},{"issue":"Suppl 214","key":"448_CR27","first-page":"7","volume":"89","author":"K Korhonen","year":"2000","unstructured":"Korhonen K. Hyperbaric oxygen therapy in acute necrotizing infections with a special reference to the effects on tissue gas tensions. Ann Chir Gynaecol Suppl. 2000;89(Suppl 214):7\u201336.","journal-title":"Ann Chir Gynaecol Suppl"},{"issue":"5","key":"448_CR28","first-page":"847","volume":"108","author":"JA Riseman","year":"1990","unstructured":"Riseman JA, Zamboni WA, Curtis A, Graham DR, Konrad HR, Ross DS. Hyperbaric oxygen therapy for necrotizing fasciitis reduces mortality and the need for debridements. Surgery. 1990;108(5):847\u201350.","journal-title":"Surgery"},{"issue":"3\u20134","key":"448_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1159\/000511615","volume":"105","author":"L Schneidewind","year":"2021","unstructured":"Schneidewind L, Anheuser P, Sch\u00f6nburg S, Wagenlehner FME, Kranz J. Hyperbaric oxygenation in the treatment of Fournier\u2019s gangrene: a systematic review. Urol Int. 2021;105(3\u20134):247\u201356.","journal-title":"Urol Int"},{"issue":"1","key":"448_CR30","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jss.2012.03.016","volume":"177","author":"PR Massey","year":"2012","unstructured":"Massey PR, Sakran JV, Mills AM, et al. Hyperbaric oxygen therapy in necrotizing soft tissue infections. J Surg Res. 2012;177(1):146\u201351.","journal-title":"J Surg Res"},{"issue":"1","key":"448_CR31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/sur.2007.085","volume":"10","author":"ME George","year":"2009","unstructured":"George ME, Rueth NM, Skarda DE, Chipman JG, Quickel RR, Beilman GJ. Hyperbaric oxygen does not improve outcome in patients with necrotizing soft tissue infection. Surg Infect (Larchmt). 2009;10(1):21\u20138.","journal-title":"Surg Infect (Larchmt)"},{"issue":"5","key":"448_CR32","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S0039-6060(05)80278-8","volume":"118","author":"A Shupak","year":"1995","unstructured":"Shupak A, Shoshani O, Goldenberg I, Barzilai A, Moskuna R, Bursztein S. Necrotizing fasciitis: an indication for hyperbaric oxygenation therapy? Surgery. 1995;118(5):873\u20138.","journal-title":"Surgery"},{"issue":"5","key":"448_CR33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/0002-9610(94)90240-2","volume":"167","author":"DR Brown","year":"1994","unstructured":"Brown DR, Davis NL, Lepawsky M, Cunningham J, Kortbeek J. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167(5):485\u20139.","journal-title":"Am J Surg"},{"issue":"6","key":"448_CR34","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1097\/01.ju.0000158129.56571.05","volume":"173","author":"SR Mindrup","year":"2005","unstructured":"Mindrup SR, Kealey GP, Fallon B. Hyperbaric oxygen for the treatment of fournier\u2019s gangrene. J Urol. 2005;173(6):1975\u20137.","journal-title":"J Urol"},{"issue":"1","key":"448_CR35","first-page":"CD007937","volume":"1","author":"D Levett","year":"2015","unstructured":"Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1(1):CD007937.","journal-title":"Cochrane Database Syst Rev."},{"issue":"4","key":"448_CR36","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.amjsurg.2005.01.012","volume":"189","author":"N Jallali","year":"2005","unstructured":"Jallali N, Withey S, Butler PE. Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis. Am J Surg. 2005;189(4):462\u20136.","journal-title":"Am J Surg"},{"issue":"11","key":"448_CR37","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1302\/0301-620X.98B11.37526","volume":"98-B","author":"JH Tan","year":"2016","unstructured":"Tan JH, Koh BT, Hong CC, et al. A comparison of necrotising fasciitis in diabetics and non-diabetics: a review of 127 patients. Bone Joint J. 2016;98-B(11):1563\u20138.","journal-title":"Bone Joint J."},{"key":"448_CR38","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12879-015-1144-0","volume":"15","author":"NC Cheng","year":"2015","unstructured":"Cheng NC, Tai HC, Chang SC, Chang CH, Lai HS. Necrotizing fasciitis in patients with diabetes mellitus: clinical characteristics and risk factors for mortality. BMC Infect Dis. 2015;15:417.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"448_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.dsx.2020.05.032","volume":"14","author":"D Naik","year":"2020","unstructured":"Naik D, Jebasingh FK, Thomas N, et al. Necrotizing soft tissue infection of the upper extremities in patients with diabetes mellitus in a tertiary care center-a retrospective study. Diabetes Metab Syndr. 2020;14(5):1071\u20135.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"448_CR40","first-page":"437","volume":"32","author":"SJ Escobar","year":"2005","unstructured":"Escobar SJ, Slade JB Jr, Hunt TK, Cianci P. Adjuvant hyperbaric oxygen therapy (HBO2) for treatment of necrotizing fasciitis reduces mortality and amputation rate. Undersea Hyperb Med. 2005;32(6):437\u201343.","journal-title":"Undersea Hyperb Med"},{"issue":"1","key":"448_CR41","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cmi.2019.06.031","volume":"26","author":"M Peetermans","year":"2020","unstructured":"Peetermans M, de Prost N, Eckmann C, Norrby-Teglund A, Skrede S, De Waele JJ. Necrotizing skin and soft-tissue infections in the intensive care unit. Clin Microbiol Infect. 2020;26(1):8\u201317.","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"448_CR42","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"}],"container-title":["World Journal of Emergency Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13017-022-00448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13017-022-00448-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13017-022-00448-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T14:04:40Z","timestamp":1659708280000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjes.biomedcentral.com\/articles\/10.1186\/s13017-022-00448-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["448"],"URL":"https:\/\/doi.org\/10.1186\/s13017-022-00448-6","relation":{},"ISSN":["1749-7922"],"issn-type":[{"value":"1749-7922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]},"assertion":[{"value":"19 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the Faculty of Medicine of Charit\u00e9 University Medicine Berlin (EA2\/296\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}